This week’s View summarizes a review article about established and emerging indications for sodium-glucose luminal cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, a scientific statement from the American Heart Association on the diagnosis and management of myocarditis in children, and a global consensus statement on transition to adulthood and transfer to adult care of adolescents with congenital heart disease.